Cingulate

Cingulate FCF Yield

The Free Cash Flow Yield of Cingulate (CING) as of Nov 11, 2026 is -21.19 %. In the previous year, Free Cash Flow Yield was -22.72 % — a change of -6.73% (higher).

FCF Yield

-21.19 %

YoY

-6.73%

Last updated:

Free Cash Flow Yield of Cingulate is 2025 -21.19 % . Free Cash Flow Yield of Cingulate was 2024 -22.72 % . It decreases by -6.73% higher compared to the previous year.

The Cingulate FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2019
-12.84 USD
Jan 1, 2020
-8.78 USD
Jan 1, 2021
-13.69 USD
Jan 1, 2022
-19.52 USD
Jan 1, 2023
-18.57 USD
Jan 1, 2024
-22.72 USD
Jan 1, 2025
-21.19 USD
The Cingulate FCF Yield history
YEARFCF YieldYoY
-21.19 %-6.73%
-22.72 %+22.31%
-18.57 %-4.85%
-19.52 %+42.58%
-13.69 %+55.93%
-8.78 %-31.62%
-12.84 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cingulate Stock analysis

What does Cingulate do? Cingulate Inc is a US-based biopharmaceutical company headquartered in Kansas City, Kansas, that focuses on the development, manufacturing, and commercialization of pharmaceutical products. The firm utilizes its precision timed release (PTR) drug delivery platform technology to create dosing schedules and drug release profiles designed to improve the lives of patients suffering from commonly diagnosed conditions. The company specifically targets the treatment of attention deficit/hyperactivity disorder (ADHD) through its innovative approach to drug delivery. The firm is currently developing two lead product candidates, CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine). These drug candidates both contain three releases of an active pharmaceutical ingredient combined into one small tablet dosage form. By employing this technology, Cingulate Inc aims to provide effective treatment options for ADHD across three core patient segments: children aged 6-12, adolescents aged 13-17, and adults aged 18 and older. Cingulate is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cingulate stock

Free Cash Flow Yield of Cingulate is -21.19 % in 2025.

Free Cash Flow Yield of Cingulate changed from -22.72 % to -21.19 %, representing a -6.73% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield Cingulate since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's Cingulate with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Cingulate

All Key Metrics — Cingulate